These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 23879205)

  • 1. Induced pluripotent stem cells from friedreich ataxia patients fail to upregulate frataxin during in vitro differentiation to peripheral sensory neurons.
    Eigentler A; Boesch S; Schneider R; Dechant G; Nat R
    Stem Cells Dev; 2013 Dec; 22(24):3271-82. PubMed ID: 23879205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of genetically modified Friedreich's ataxia induced pluripotent stem cell lines and isogenic control lines carrying an inducible neurogenin-2 expression cassette.
    Miellet S; Maddock M; Napierala JS; Napierala M; Dottori M
    Stem Cell Res; 2024 Sep; 79():103477. PubMed ID: 38936158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional profiling of isogenic Friedreich ataxia neurons and effect of an HDAC inhibitor on disease signatures.
    Lai JI; Nachun D; Petrosyan L; Throesch B; Campau E; Gao F; Baldwin KK; Coppola G; Gottesfeld JM; Soragni E
    J Biol Chem; 2019 Feb; 294(6):1846-1859. PubMed ID: 30552117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of mismatch repair enzymes in GAA·TTC triplet-repeat expansion in Friedreich ataxia induced pluripotent stem cells.
    Du J; Campau E; Soragni E; Ku S; Puckett JW; Dervan PB; Gottesfeld JM
    J Biol Chem; 2012 Aug; 287(35):29861-72. PubMed ID: 22798143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frataxin deficiency alters gene expression in Friedreich ataxia derived IPSC-neurons and cardiomyocytes.
    Angulo MB; Bertalovitz A; Argenziano MA; Yang J; Patel A; Zesiewicz T; McDonald TV
    Mol Genet Genomic Med; 2023 Jan; 11(1):e2093. PubMed ID: 36369844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation and characterization of iPSC lines from Friedreich's ataxia patient (FRDA) with GAA.TTC repeat expansion in the Frataxin (FXN) gene's first intron (IGIBi016-A) and a non-FRDA healthy control individual (IGIBi017-A).
    Ahmad I; Kamai A; Zahra S; Kapoor H; Kumar Srivastava A; Faruq M
    Stem Cell Res; 2024 Jun; 77():103382. PubMed ID: 38484450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Friedreich's ataxia induced pluripotent stem cell-derived cardiomyocytes display electrophysiological abnormalities and calcium handling deficiency.
    Crombie DE; Curl CL; Raaijmakers AJ; Sivakumaran P; Kulkarni T; Wong RC; Minami I; Evans-Galea MV; Lim SY; Delbridge L; Corben LA; Dottori M; Nakatsuji N; Trounce IA; Hewitt AW; Delatycki MB; Pera MF; Pébay A
    Aging (Albany NY); 2017 May; 9(5):1440-1452. PubMed ID: 28562313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo survival and differentiation of Friedreich ataxia iPSC-derived sensory neurons transplanted in the adult dorsal root ganglia.
    Viventi S; Frausin S; Howden SE; Lim SY; Finol-Urdaneta RK; McArthur JR; Abu-Bonsrah KD; Ng W; Ivanusic J; Thompson L; Dottori M
    Stem Cells Transl Med; 2021 Aug; 10(8):1157-1169. PubMed ID: 33734599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frataxin gene editing rescues Friedreich's ataxia pathology in dorsal root ganglia organoid-derived sensory neurons.
    Mazzara PG; Muggeo S; Luoni M; Massimino L; Zaghi M; Valverde PT; Brusco S; Marzi MJ; Palma C; Colasante G; Iannielli A; Paulis M; Cordiglieri C; Giannelli SG; Podini P; Gellera C; Taroni F; Nicassio F; Rasponi M; Broccoli V
    Nat Commun; 2020 Aug; 11(1):4178. PubMed ID: 32826895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurons and cardiomyocytes derived from induced pluripotent stem cells as a model for mitochondrial defects in Friedreich's ataxia.
    Hick A; Wattenhofer-Donzé M; Chintawar S; Tropel P; Simard JP; Vaucamps N; Gall D; Lambot L; André C; Reutenauer L; Rai M; Teletin M; Messaddeq N; Schiffmann SN; Viville S; Pearson CE; Pandolfo M; Puccio H
    Dis Model Mech; 2013 May; 6(3):608-21. PubMed ID: 23136396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of induced pluripotent stem cell lines from Friedreich ataxia patients.
    Liu J; Verma PJ; Evans-Galea MV; Delatycki MB; Michalska A; Leung J; Crombie D; Sarsero JP; Williamson R; Dottori M; Pébay A
    Stem Cell Rev Rep; 2011 Sep; 7(3):703-13. PubMed ID: 21181307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon gamma upregulates frataxin and corrects the functional deficits in a Friedreich ataxia model.
    Tomassini B; Arcuri G; Fortuni S; Sandi C; Ezzatizadeh V; Casali C; Condò I; Malisan F; Al-Mahdawi S; Pook M; Testi R
    Hum Mol Genet; 2012 Jul; 21(13):2855-61. PubMed ID: 22447512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PPAR gamma agonist leriglitazone improves frataxin-loss impairments in cellular and animal models of Friedreich Ataxia.
    Rodríguez-Pascau L; Britti E; Calap-Quintana P; Dong YN; Vergara C; Delaspre F; Medina-Carbonero M; Tamarit J; Pallardó FV; Gonzalez-Cabo P; Ros J; Lynch DR; Martinell M; Pizcueta P
    Neurobiol Dis; 2021 Jan; 148():105162. PubMed ID: 33171227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GRP75 overexpression rescues frataxin deficiency and mitochondrial phenotypes in Friedreich ataxia cellular models.
    Dong YN; McMillan E; Clark EM; Lin H; Lynch DR
    Hum Mol Genet; 2019 May; 28(10):1594-1607. PubMed ID: 30590615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using human pluripotent stem cells to study Friedreich ataxia cardiomyopathy.
    Crombie DE; Pera MF; Delatycki MB; Pébay A
    Int J Cardiol; 2016 Jun; 212():37-43. PubMed ID: 27019046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Excision of the expanded GAA repeats corrects cardiomyopathy phenotypes of iPSC-derived Friedreich's ataxia cardiomyocytes.
    Li J; Rozwadowska N; Clark A; Fil D; Napierala JS; Napierala M
    Stem Cell Res; 2019 Oct; 40():101529. PubMed ID: 31446150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation and characterisation of Friedreich ataxia YG8R mouse fibroblast and neural stem cell models.
    Sandi C; Sandi M; Jassal H; Ezzatizadeh V; Anjomani-Virmouni S; Al-Mahdawi S; Pook MA
    PLoS One; 2014; 9(2):e89488. PubMed ID: 24586819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alleviating GAA Repeat Induced Transcriptional Silencing of the Friedreich's Ataxia Gene During Somatic Cell Reprogramming.
    Polak U; Li Y; Butler JS; Napierala M
    Stem Cells Dev; 2016 Dec; 25(23):1788-1800. PubMed ID: 27615158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exenatide induces frataxin expression and improves mitochondrial function in Friedreich ataxia.
    Igoillo-Esteve M; Oliveira AF; Cosentino C; Fantuzzi F; Demarez C; Toivonen S; Hu A; Chintawar S; Lopes M; Pachera N; Cai Y; Abdulkarim B; Rai M; Marselli L; Marchetti P; Tariq M; Jonas JC; Boscolo M; Pandolfo M; Eizirik DL; Cnop M
    JCI Insight; 2020 Jan; 5(2):. PubMed ID: 31877117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central role and mechanisms of β-cell dysfunction and death in friedreich ataxia-associated diabetes.
    Cnop M; Igoillo-Esteve M; Rai M; Begu A; Serroukh Y; Depondt C; Musuaya AE; Marhfour I; Ladrière L; Moles Lopez X; Lefkaditis D; Moore F; Brion JP; Cooper JM; Schapira AH; Clark A; Koeppen AH; Marchetti P; Pandolfo M; Eizirik DL; Féry F
    Ann Neurol; 2012 Dec; 72(6):971-82. PubMed ID: 23280845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.